almost significantlyp = 0.048
11.0%; p = 0.036); at last, the included population underwent previous or concomitant allergen immunotherapy almost significantly more than the excluded group (7.9% vs. 7.3%; p = 0.048).
11.0%; p = 0.036); at last, the included population underwent previous or concomitant allergen immunotherapy almost significantly more than the excluded group (7.9% vs. 7.3%; p = 0.048).